Form 8-K - Current report:
SEC Accession No. 0001493152-24-051091
Filing Date
2024-12-20
Accepted
2024-12-20 17:00:32
Documents
15
Period of Report
2024-12-16
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46070
2 ex16-1.htm EX-16.1 5882
3 ex16-1_001.jpg GRAPHIC 17851
  Complete submission text file 0001493152-24-051091.txt   257078

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE mira-20241216.xsd EX-101.SCH 3048
5 XBRL LABEL FILE mira-20241216_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE mira-20241216_pre.xml EX-101.PRE 24187
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3813
Mailing Address 324 SOUTH HYDE PARK AVENUE, SUITE 350 TAMPA FL 33606
Business Address 1200 BRICKELL AVENUE SUITE 1950 #1183 MIAMI FL 33131 813-369-5150
MIRA PHARMACEUTICALS, INC. (Filer) CIK: 0001904286 (see all company filings)

EIN.: 853354547 | State of Incorp.: FL
Type: 8-K | Act: 34 | File No.: 001-41765 | Film No.: 241568753
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)